Zenabis Provides Operations Update and Highlights for December 2019
Ryan Allway
February 6th, 2020
News
VANCOUVER, Feb. 5, 2020 /CNW/ – Zenabis Global Inc. (TSX: ZENA) (“Zenabis” or the “Company“) is pleased to provide an update on its recent facility construction and licensing activities, sales and marketing highlights and recent cannabis production results.
“December 2019 delivered our largest-ever harvest. This completes a whole year of successful harvests from Zenabis Atholville, since the creation of Zenabis Global Inc. In that time, we have increased Atholville monthly harvest yields by 800%, which is an amazing achievement by the entire Zenabis team,” said Kevin Coft, Chief Executive Officer of Zenabis. “Of the total 2019 Atholville harvest figure of nearly 20,000 kg, 20% was harvested just in December. This shows us what steady-state cultivation and production at Atholville can deliver. We are looking forward to achieving steady-state production at Langley with more license amendments in progress.”
“We also realized strong indicative demand from our provincial partners in December, resulting in our largest-ever volume of units shipped in the month. We are excited about what 2020 will bring,” continued Mr. Coft.
Cannabis Production Summary
In December 2019, Zenabis realized a total harvest weight of 3,841 kg of dried cannabis.
The amount harvested at Zenabis Atholville for the twelve months ending December 2019 outperformed the revised design capacity of the flower rooms by 0.93%, harvesting a total of 19,420 kg of dried cannabis. A month-to-month comparison of actual harvests compared with harvest forecast based on the revised design capacity for the last twelve months for Zenabis Atholville is provided in the table below.
|
Revised Design Capacity |
Jan 2019 |
Feb |
Mar |
Apr 2019 |
May 2019 |
June 2019 |
July 2019 |
Aug |
Sept 2019 |
Oct 2019 |
Nov 2019 |
Dec 2019 |
Total |
|
Actual Harvest Weight (kg) |
474 |
480 |
518 |
809 |
908 |
756 |
1,238 |
1,912 |
2,089 |
3,586 |
2,810 |
3,841 |
19,420 |
|
Revised Design Capacity |
467 |
643 |
539 |
796 |
895 |
716 |
1,097 |
1,357 |
1,715 |
3,601 |
2,940 |
4,476 |
19,242 |
|
Difference (kg) |
7 |
(163) |
(21) |
13 |
13 |
40 |
141 |
555 |
374 |
(15) |
(130) |
(635) |
179 |
|
Difference (%) – Revised |
1.5% |
(25.3%) |
(3.9%) |
1.6% |
1.5% |
5.6% |
12.9% |
40.9% |
21.8% |
(0.4)% |
(4.4)% |
(14.2)% |
0.93% |
|
1 |
The Revised Design Capacity Harvest Weight was derived by converting the actual square footage of flower room space and the forecast canopy for each specific flower room into a kilograms per room per day figure based on Zenabis’ historical yield data at the Zenabis Atholville facility based on the yield performance in the three months ending June 2019 for revised Design Capacity. The Revised Design Capacity Harvest Weight in the table above is the harvest weight that would have resulted if the Design Capacity Yield Per Day for a room was multiplied by the Effective Flower Room Equivalent Days, as defined under “Performance Ratio”. |
In December 2019, Zenabis completed 23 harvests at Zenabis Atholville. Zenabis did not complete any harvests at Zenabis Langley or Zenabis Stellarton.
Harvest Forecast – Zenabis Atholville, Zenabis Stellarton and Zenabis Langley Site A – Part 1
The following table sets out Zenabis’ estimated aggregate monthly harvest for Zenabis Atholville, Zenabis Stellarton and Zenabis Langley Site A – Part 1 from September 2019 to January 2020.
|
Sept 2019 |
Oct 2019 |
Nov 2019 |
Dec 2019 |
Jan 2020 |
Total |
|
|
Forecast (kg)3 |
1,731 |
3,758 |
3,881 |
4,2002 |
3,576 |
17,146 |
|
Actual (kg) |
2,089 |
3,586 |
3,332 |
3,841 |
12,848 |
|
2 |
Zenabis calculates the Revised Design Capacity Harvest Weight based on a continuous harvest cycle. A variance between the Forecast and Revised Design Capacity Harvest Weight for Zenabis Atholville would be a result of a variance in the average continuous flower days during the month. |
|
3 |
This forward-looking estimate of future harvest results is based on the following material assumptions: (1) Zenabis Stellarton operates at the published design capacity on a room by room basis for the cultivation space that is licensed and in cultivation at the forward-looking periods noted; (2) Zenabis Atholville rooms operate based on the current flower schedule and continue to achieve revised Design Capacity. |
Construction and Facility Licensing Update
Zenabis Langley
Zenabis Langley Part 1 and Part 2A are licensed and operational. Zenabis Langley Part 2B is substantially complete and the license amendment was submitted in December 2019. After reviewing the construction and licensing progress of Zenabis Langley, Zenabis decided to amend the Part 2B license amendment submission further to include more square footage that was originally intended for Part 2C. This includes an increase of approximately 2,500 sq. ft. of flower space and 18,000 sq. ft. of operational space which includes drying rooms and packaging rooms. Construction of Zenabis Langley Part 2C is ongoing but at a reduced pace as the Company’s focus for Zenabis Langley is for the existing licensed or substantially completed space to achieve operational excellence and operate at a steady state.
A summary of construction status by phase is provided below:
|
Phase |
Design Capacity |
Description |
|
Part 1 |
9,900 kg |
• Licensed and operational |
|
Part 2A |
39,400 kg |
• Licensed and operational |
|
Part 2B |
14,800 kg |
• Consists of 40,500 sq. ft. of flower room space (one flower room) and • Substantially complete • License amendment submitted in December 2019 |
|
Part 2C |
32,000 kg |
• Consists of 82,200 sq. ft. of flower room space (two flower rooms) and • HVAC, flooring and shade screen installation is ongoing • Security equipment and lighting installation is substantially complete |
Zenabis Stellarton
Zenabis has submitted a sales license application for Zenabis Stellarton and expects to use this site as a fulfilment centre and packaging/processing facility upon receipt of this license.
Zenabis Delta
As the Company continues to focus on becoming cash flow positive, the further conversion of Zenabis Delta is under review to assess whether its analytical and laboratory services are justified by market demand. Zenabis is also considering other plans for the Delta facility if it determines market demand is insufficient.
Licensing Update
Zenabis is currently in the process of various licensing applications for Zenabis Delta, Zenabis Langley, Zenabis Stellarton and the Zen Craft Grow program as outlined in the table below:
|
License Submission |
Submission Month |
Annual Design Capacity |
|
Zenabis Delta – Analytical Testing |
May 2019 |
N/A |
|
Zen Craft Grow – Grower 1 |
July 2019 |
350 kg |
|
Zenabis Stellarton – Sales License |
October 2019 |
N/A |
|
Zenabis Langley Site A – Part 2B |
December 2019 |
14,800 kg |
|
Zenabis Langley Site A – Part 2C |
TBD4 |
32,000 kg |
|
4 |
Expected submission timeline subject to receipt of prior license or license amendment for each facility. |
Sales and Marketing Update
Compassionate Pricing Program
To increase medical patient access to cannabis products, and to compete with the illicit market, Zenabis will be lowering its medical cannabis pricing across the board for all applicable medical patients and is offering compassionate pricing on cannabis products including dried flower and cannabis oil products for qualifying customers through its Compassionate Pricing Program.
About Zenabis
Zenabis is a significant Canadian licensed cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta, Aldergrove, Pitt Meadows and Langley, British Columbia; and Stellarton, Nova Scotia. Zenabis currently has 96,400 kg of licensed cannabis cultivation space and four licensed facilities. Zenabis has 3.5 million square feet of total facility space dedicated to a mix of cannabis production and cultivation and its non-cannabis propagation and floral business.
Zenabis expects its Zenabis Atholville, Zenabis Stellarton and Zenabis Langley facilities to be in steady state production in 2020. The Zenabis brand name is used in the cannabis medical market, the Namaste, Blazery, and Re-Up brand names are used in the cannabis adult-use recreational market, and the True Büch brand name is used for Zenabis’ kombucha products.
Forward Looking Information
This news release contains statements that may constitute “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information may include, among others, statements regarding the future plans, costs, objectives or performance of Zenabis, or the assumptions underlying any of the foregoing. In this news release, words such as “may”, “would”, “could”, “will”, “likely”, “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate” and similar words and the negative form thereof are used to identify forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the projected kilogram yield of licensed facility space and facility space in the process of, or scheduled for, construction and/or licensing; our expectations for future harvests; the expected timing and completion of current and planned conversion, expansion and optimization of our facilities, including Zenabis Langley; the expected submissions of license amendment applications and site evidence packages; the licensing of our facilities and projected timing thereof; our expectations for our extraction projects, equipment and capacity; our expectations for processing output; the pricing for our compassionate pricing program and the expected content of future operational updates. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management’s good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Zenabis’ control. These risks, uncertainties and assumptions include, but are not limited to, those described in the shelf prospectus dated April 9, 2019, a copy of which is available on SEDAR at www.sedar.com and could cause actual events or results to differ materially from those projected in any forward-looking statements. Furthermore, any forward-looking information with respect to available space for cannabis production is subject to the qualification that management of Zenabis may decide not to use all available space for cannabis production, and the assumptions that any construction or conversion would not be cost prohibitive, required permits will be obtained and the labour, materials and equipment necessary to complete such construction or conversion will be available. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Zenabis does not intend, nor undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws
For more information, visit: https://www.zenabis.com.
SOURCE Zenabis Global Inc.
For further information: Media Relations: Email: media@zenabis.com, Phone: 1-855-936-2247; Investor Relations: E-mail: invest@zenabis.com, Phone: 1-855-936-2247
Related Links
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
FinCanna is a royalty company that provides growth capital to rapidly emerging private companies operating in the licensed U.S cannabis industry.
New You, Inc. (OTCQB: NWYU) wholly-owned subsidiary, ST Brands Corp is a holding company of branded assets that create, develop, market, and sell unique and proprietary cannabidiol (“CBD”) products to various segments of the global consumer market.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
